CXCL10 and neoplasm: Meanwhile, autocrine IFNs mediated CXCL10 and ICAM-1 expression in RT-treated tumors, which is potential to enhance LFA-1-ICAM-1 interaction for further activating anti-tumor CD8+ T cells (Fig. 7C).